title: Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.
abstract: Coenzyme Q10 (CoQ10) is an antioxidant, a membrane stabilizer, and a vital cofactor in the mitochondrial electron transport chain, enabling the generation of adenosine triphosphate. It additionally regulates gene expression and apoptosis; is an essential cofactor of uncoupling proteins; and has anti-inflammatory, redox modulatory, and neuroprotective effects. This paper reviews the known physiological role of CoQ10 in cellular metabolism, cell death, differentiation and gene regulation, and examines the potential repercussions of CoQ10 depletion including its role in illnesses such as Parkinson's disease, depression, myalgic encephalomyelitis/chronic fatigue syndrome, and fibromyalgia. CoQ10 depletion may play a role in the pathophysiology of these disorders by modulating cellular processes including hydrogen peroxide formation, gene regulation, cytoprotection, bioenegetic performance, and regulation of cellular metabolism. CoQ10 treatment improves quality of life in patients with Parkinson's disease and may play a role in delaying the progression of that disorder. Administration of CoQ10 has antidepressive effects. CoQ10 treatment significantly reduces fatigue and improves ergonomic performance during exercise and thus may have potential in alleviating the exercise intolerance and exhaustion displayed by people with myalgic encepholamyletis/chronic fatigue syndrome. Administration of CoQ10 improves hyperalgesia and quality of life in patients with fibromyalgia. The evidence base for the effectiveness of treatment with CoQ10 may be explained via its ability to ameliorate oxidative stress and protect mitochondria.
authors.affiliation: , Tir Na Nog, Bryn Road seaside 87, Llanelli, SA152LW, Wales, UK.
authors.forename: Gerwyn
authors.initials: G
authors.lastname: Morris
authors.forename: George
authors.initials: G
authors.lastname: Anderson
authors.forename: Michael
authors.initials: M
authors.lastname: Berk
authors.forename: Michael
authors.initials: M
authors.lastname: Maes
mesh_terms: D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000503:physiopathology; D015538:Nitrosation; D018384:Oxidative Stress; D015398:Signal Transduction; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000172:deficiency / Q000627:therapeutic use
chemical_list: D014451:Ubiquinone; C024989:coenzyme Q10